Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.45
-1.50 (-3.58%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.94 billion as of September 18, 2026. Its market cap has increased by 60.02% in one year.
Market Cap
1.94B
Enterprise Value
1.51B
1-Year Change
60.02%
Ranking
Category
Stock Price
$40.45
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.94B, an increase of 222.70%. That is a compound annual growth rate of 67.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.94B | 34.21% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.05B |
| Kodiak Sciences | 2.02B |
| ADMA Biologics | 2.00B |
| Recursion Pharmaceuticals | 1.99B |
| Agios Pharmaceuticals | 1.97B |
| Hemab Therapeutics Holdings | 1.95B |
| Mesoblast | 1.95B |
| GH Research | 1.94B |